ERFSF (ERFSF) Stock Price & Analysis
ERFSF (ERFSF) rose 0.72% to USD 73 as of June 10, 2026 at 02:27 UTC, according to Nexqual real-time market data.
ERFSF last closed at USD 72.48; the session ranged USD 73–73 on volume of 100 shares. Market capitalization is $12.75B, with a 52-week range of USD 64.95–86.2 (PNK). Source: Nexqual, June 10, 2026 at 02:27 UTC.
Key Statistics (as of June 10, 2026 at 02:27 UTC)
| Price | USD 73 |
|---|---|
| Change | ▲ 0.72% (up) |
| Previous Close | USD 72.48 |
| Open | USD 73 |
| Day Range | USD 73 – 73 |
| 52-Week Range | USD 64.95 – 86.2 |
| Volume | 100 shares |
| Market Cap | $12.75B |
| Exchange | PNK |
Technical Analysis (ERFSF)
Nexqual's technical model rates ERFSF "NEUTRAL" based on 3 bullish and 2 bearish signals across 123 daily candles, as of June 10, 2026 at 02:27 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.65 (neutral) |
| vs SMA50 | Below (USD 73.38) |
| MACD | 0.39 (positive) |
Analyst Ratings (ERFSF)
Wall Street analysts rate ERFSF "None", per Nexqual as of June 10, 2026 at 02:27 UTC.
| Consensus Rating | None |
|---|
Earnings (ERFSF)
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Financials & Fundamentals (ERFSF)
| Total Revenue | $7.30B |
|---|---|
| Revenue Growth (YoY) | +4.30% |
| Gross Margin | +22.49% |
| Operating Margin | +13.25% |
| Profit Margin | +6.51% |
| ROE | +9.50% |
| Debt / Equity | 96.84 |
| Current Ratio | 1.09 |
| Total Cash | $794.20M |
| Total Debt | $4.43B |
| Free Cash Flow | $492.52M |
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Financial Health Score (ERFSF)
Nexqual rates ERFSF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:27 UTC.
| Growth | Mixed — Revenue +5.0% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 22%, operating 13% |
| Balance Sheet | Mixed — $794M cash vs $4.43B debt |
| Cash Flow | Solid — FCF $493M, 7% margin |
| Efficiency | Mixed — ROE 9%, ROA 5.5% |
Ownership (ERFSF)
| Insider Ownership | +36.50% |
|---|---|
| Institutional Ownership | +35.14% |
| Shares Outstanding | 174.71M |
| Float | 112.79M |
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Leadership (ERFSF)
ERFSF is led by Gilles G. Martin (age 62), Chairman of the Board & CEO, per Nexqual as of June 10, 2026 at 02:27 UTC.
| Chairman of the Board & CEO | Gilles G. Martin (age 62) |
|---|---|
| Executive Director | Valerie Hanote (age 59) |
| Group Administration & CFO | Laurent Lebras |
| Senior Vice President of Food & Feed Testing Europe | Joachim Reichelt |
| Senior Vice President of Environment Testing Europe | Yvoine Remy |
Major Backers & Investors (ERFSF)
Notable institutional backers of ERFSF include Gardner Russo & Quinn, LLC, SEQUOIA FUND INC, FPA FUNDS TRUST-FPA Crescent Fund, according to Nexqual as of June 10, 2026 at 02:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Gardner Russo & Quinn, LLC | 1.76% |
| SEQUOIA FUND INC | 1.66% |
| FPA FUNDS TRUST-FPA Crescent Fund | 0.94% |
| T. Rowe Price | 0.39% |
| TRANSAMERICA FUNDS-Transamerica International Equity | 0.3% |
| EuroPacific Growth Fund-EUPAC Fund | 0.29% |
| AMERICAN FUNDS INSURANCE SERIES-International Fund | 0.25% |
| Fidelity | 0.25% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.55% |
| BlackRock | 0.49% |
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BMXMF | Biomerieux 69 Marcy L'Etoile | USD 84 | ▼ 0.09% |
| LZAGF | Lonza Group AG | USD 615.21 | ▼ 2.89% |
| SAUHF | STRAUMANN HOLDING AG | USD 109 | ▼ 8.46% |
| GNMSF | Genmab A/S | USD 249 | ▼ 0.18% |
| SKHCF | Sonic Healthcare Ltd. | USD 14.58 | ▲ 21.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:27 UTC. This page is informational and not investment advice.